CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 23 enrolled
Drug / intervention
Mirabegron +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02436889
NCT02436889Phase 4Completed
CompareCT.gov

Treatment of Incontinence Without Memory Problems

University of California, San Francisco·interventional·Posted May 7, 2015·Updated Apr 16, 2019

In Brief

A Phase 4 clinical trial evaluating Mirabegron and Tolterodine Tartrate for Urge Incontinence and Urinary Incontinence, Urge. Completed, enrolled 23 participants across 1 site.

Detailed Summary

An 8-week randomized, controlled, pilot clinical trial of Mirabegron compared to a standard anticholinergic therapy (Detrol LA) in elderly women with urgency urinary incontinence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrge Incontinence, Urinary Incontinence, Urge
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20162017201820192020202120222023202420252026
First PostedMay 7, 2015
Enrollment StartFeb 1, 2016
Primary CompletionDec 1, 2017
Study CompletionJul 1, 2018
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 11.2 years ago

Interventions

Mirabegrondrug

Tolterodine Tartratedrug